Background: This study reports the feasibility, validity and reliability of the Turkish versions of the Esophageal-Atresia–Quality-of-Life (EA-QOL) questionnaires, which were originally developed in Sweden and Germany. Methods: After translation from Swedish to Turkish and cognitive debriefings, 51 families of children aged 2 to 7 years (parent-report, 17-items) and 54 families of children 8 to 17 years (child and parent-report, 24-items) responded to the EA-QOL questionnaires and a validated generic HRQOL-instrument (PedsQL4.0). Medical records of patients and questionnaires were used to obtain clinical data. The Turkish version of the EA-QOL questionnaires were evaluated for feasibility (<5% missing item responses), reliability (internal consistency/retest reliability for 3 weeks) and validity (known-groups/concurrent/convergent). Level of significance was p<0.05. Results: Feasibility of the Turkish version of the EA-QOL questionnaires was good. Internal consistency of all scales was satisfactory, as were the level of agreements of EA-QOL scores between the field- and retest study. Known-group and concurrent validity were achieved since the EA-QOL questionnaires showed that esophageal symptoms and feeding difficulties were negatively associated with EA-QOL total scores in both age specific versions (child-and parent report), and respiratory symptoms in the version for EA children 2 to 7 years (parent-report). A higher number of respiratory symptoms decreased the EA-QOL total scores in both age groups (parent-report, p<0.05). Correlations between the EA-QOL total scores and PedsQL-4.0 total scores supported convergent validity. Conclusion: The Turkish version of the EA-QOL questionnaires are feasible, valid and reliable to assess condition-specific HRQOL in EA children.
Background. This study aimed to evaluate general and condition-specific quality of life in esophageal atresia (EA) patients, identifying risk factors such as associated anomalies and chronic diseases, as well as examining their impact on life quality. Methods. Patients operated on for EA between 2004 and 2020 comprised the study population. Pediatric Quality of Life (PedsQOL 4.0) and the Esophageal Atresia Quality of Life (EA-QOL) questionnaires were administered to parents of 2-7 year old children as well as both patients aged 8-17 year and their parents. Results of the PedsQOL 4.0 scale were compared with 43 healthy children. Results. The study included 66 patients (40 aged 2-7 years, 26 aged 8-17 years), with 45.5% females and 54.5% males. The mean age was 7±4.4 years. Quality of life measured by EA-QOL and PedsQOL 4.0 questionnaires showed no significant differences based on patient sex, gestational age or having an anastomotic stricture. In the 8-17 age group, EA patients demonstrated significantly higher emotional scale quality of life than the healthy group (p=0.001) according to parent and child PedsQOL 4.0 questionnaire scores. Conclusions. The better emotional functioning in the 8-17 age group supports their enhanced anxiety management. Sex, gestational age, or presence of an anastomotic stricture did not impact quality of life. While differences existed between patient age groups in the questionnaires administered, factors like anatomical EA type, repair mode, low birth weight, tracheomalacia, frequent lung infections, presence of associated vertebral, anorectal, cardiac, renal, limb anomalies and/or hydrocephalus (VACTERL-H), gastrostomy placement, and surgical interventions other than EA significantly influenced patients’ quality of life. These findings may guide implementing measures to enhance quality of life in EA patients.
Background: Congenital diaphragmatic hernia (CDH) remains a life-threatening condition with high neonatal mortality. Identifying reliable preoperative prognostic indicators is essential for optimizing surgical timing and improving outcomes. Methods: This retrospective observational study included all neonates diagnosed with CDH admitted to a neonatal intensive care unit without extracorporeal membrane oxygenation facilities between January 2018 and December 2023. Preoperative vasoactive-inotropic score (VIS), presence and severity of persistent pulmonary hypertension of the newborn (PPHN), and blood gas parameters were analyzed in relation to surgical readiness—defined according to the 2015 CDH EURO Consortium Consensus guidelines—and short-term survival outcomes. Results: Thirty-one neonates were analyzed; PPHN was present in 83.9% and severe in 30.8%. Only 20% of surgical patients met full readiness criteria. Compared with the non-readiness group, these infants had significantly lower preoperative FiO₂ requirements (median 30% [IQR 25.5–37.5] vs. 80% [IQR 32.5–100], p = 0.028) and lactate levels (median 1.5 mmol/L [IQR 1.5–1.75] vs. 1.52 mmol/L [IQR 2.5–4.95], p = 0.002). Mortality was lower in the readiness group (20% vs. 65%), although not statistically significant ( p = 0.096). VIS, presence/severity of PPHN, and other blood gas parameters were not significantly associated with survival (all p > 0.05). Conclusion: In neonates with CDH, fulfilling surgical readiness criteria—particularly lower preoperative FiO₂ and lactate levels—appears to be associated with improved survival, whereas VIS, PPHN, and blood gas parameters alone may not reliably predict outcomes. These findings highlight the importance of comprehensive preoperative optimization over reliance on single physiological markers.
Congenital esophageal stenosis (CES) is a rare congenital disorder which may be isolated or associated with esophageal atresia (EA). It courses with esophageal outflow tract obstruction. Esophageal epiphrenic diverticulae are esophageal outpouchings above diaphragm which develop because of an underlying esophageal motor disorder. We present an infant who had CES associated with EA detected during the course of routine follow-up. She underwent several sessions of esophageal balloon dilatations for CES with some symptomatic improvement. However, an epiphrenic diverticulum (ED) developed during the course of treatment which was detected by further investigations. A surgical excision was performed with a successful outcome. An ED developed secondary to CES has not been previously reported. We have highlighted the diagnostic modalities employed, treatment options, and clinical follow-up for these two rare conditions in children.
Purpose: To investigate the early and late effects of hydroxychloroquine (HCQ) on inflammation, fibrosis, and apoptosis in an experimental rat model of pulmonary contusion. Methods: Thirty-five male Wistar albino rats were randomly allocated into five groups (n = 7): control, pulmonary contusion evaluated on day 3 or day 10 (PC-3 and PC-10), and pulmonary contusion treated with HCQ at 100 mg/kg/day by gavage and evaluated on day 3 or day 10 (PCHCQ-3 and PCHCQ-10). Lung injury was assessed histopathologically by alveolar edema, congestion, leukocyte infiltration, and fibrosis scores and immunohistochemically by caspase-3, inducible nitric oxide synthase (iNOS), and endothelial nitric oxide synthase (eNOS) expression. Results: No alveolar edema was observed. Congestion and leukocyte infiltration were significantly greater in all contusion groups than in the control group. Fibrotic changes were detected on day 10 in both treated and untreated contusion groups. Caspase-3 and iNOS expression were significantly higher in the contusion groups than in the control group. HCQ did not significantly reduce leukocyte infiltration, fibrosis, apoptosis, or iNOS expression compared with the corresponding untreated groups. Conclusion: HCQ administered at 100 mg/kg/day for three or 10 days did not demonstrate significant anti-inflammatory, anti-apoptotic, or antifibrotic effects in this rat model of pulmonary contusion.